Osaic Holdings
OTLK icon

Osaic Holdings’s Outlook Therapeutics OTLK Stock Holding History

Osaic Holdings’s Portfolio OTLK Stock Details OTLK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.53K Sell
7,303
-1,670
-19% -$722 ﹤0.01% 7134
2025
Q4 		$14.2K Hold
8,973
– – ﹤0.01% 6103
2025
Q3 		$9.51K Buy
8,973
+5,633
+169% +$9.74K ﹤0.01% 6396
2025
Q2 		$5.34K Buy
+3,340
New +$5.33K ﹤0.01% 6505
2025
Q1 		– Sell
-3,384
Closed -$6.4K – 7650
2024
Q4 		$6.4K Hold
3,384
– – ﹤0.01% 6053
2024
Q3 		$18.1K Hold
3,384
– – ﹤0.01% 5447
2024
Q2 		$25K Buy
3,384
+3,181
+1,567% +$25.5K ﹤0.01% 5183
2024
Q1 		$2.42K Sell
203
-1,824
-90% -$14.7K ﹤0.01% 6398
2023
Q4 		$16K Sell
2,027
-1,323
-39% -$11.2K ﹤0.01% 5603
2023
Q3 		$14.8K Buy
3,350
+2,150
+179% +$47.6K ﹤0.01% 5717
2023
Q2 		$41.7K Buy
1,200
+103
+9% +$2.81K ﹤0.01% 5055
2023
Q1 		$23.9K Buy
1,097
+321
+41% +$7.18K ﹤0.01% 5468
2022
Q4 		$16.3K Buy
776
+112
+17% +$2.44K ﹤0.01% 5699
2022
Q3 		$16K Sell
664
-38
-5% -$884 ﹤0.01% 5755
2022
Q2 		$14K Sell
702
-222
-24% -$6.38K ﹤0.01% 5861
2022
Q1 		$33K Sell
924
-535
-37% -$16.7K ﹤0.01% 5387
2021
Q4 		$40K Sell
1,459
-53
-4% -$1.89K ﹤0.01% 5308
2021
Q3 		$66K Sell
1,512
-1,681
-53% -$81.1K ﹤0.01% 4892
2021
Q2 		$158K Sell
3,193
-78
-2% -$3.62K ﹤0.01% 4072
2021
Q1 		$147K Sell
3,271
-160
-5% -$6.13K ﹤0.01% 4027
2020
Q4 		$89K Sell
3,431
-408
-11% -$8.53K ﹤0.01% 4134
2020
Q3 		$55K Buy
3,839
+1,357
+55% +$30.2K ﹤0.01% 4229
2020
Q2 		$64K Buy
2,482
+40
+2% +$713 ﹤0.01% 4017
2020
Q1 		$30K Buy
+2,442
New +$40.5K ﹤0.01% 4363

Other funds holding OTLK

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
GWM
Gilpin Wealth Management Denver, Colorado $126M AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return
WAM
Warberg Asset Management Winnetka, Illinois $600M AUM 23.37% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
NMC
Nine Masts Capital Central, Hong Kong $693M AUM 31.93% 1-Year Est. Return
CCM
Connective Capital Management Palo Alto, California $121M AUM 39.82% 1-Year Est. Return

Osaic Holdings's OTLK Position: Q1 2026 in Review

Osaic Holdings reduced its Outlook Therapeutics (OTLK) stake by 19% in Q1 2026, selling an estimated $722 and leaving 7,303 shares worth $1.53K. The position accounts for ﹤0.01% of the portfolio, ranked #7134.

Osaic Holdings first reported a position in OTLK in Q1 2020 and has held it in 24 quarters since. The position peaked at $158K in Q2 2021. 54 funds tracked by Wall St. Rank hold OTLK as of Q1 2026.

  • Osaic Holdings held 7,303 shares of Outlook Therapeutics worth $1.53K as of Q1 2026.
  • Osaic Holdings sold 1,670 Outlook Therapeutics shares in Q1 2026, an estimated $722.
  • Outlook Therapeutics made up ﹤0.01% of Osaic Holdings's portfolio in Q1 2026, its #7134 holding.
  • Osaic Holdings first reported a position in Outlook Therapeutics in Q1 2020 and has held it in 24 quarters since.
  • Osaic Holdings's Outlook Therapeutics position peaked at $158K in Q2 2021.
  • 54 funds tracked by Wall St. Rank held Outlook Therapeutics as of Q1 2026.

Based on Osaic Holdings's 13F filing for Q1 2026, filed 15 May 2026.